233 related articles for article (PubMed ID: 10809293)
1. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bradykinin B2 receptor preserves microcirculation in experimental pancreatitis in rats.
Bloechle C; Kusterer K; Kuehn RM; Schneider C; Knoefel WT; Izbicki JR
Am J Physiol; 1998 Jan; 274(1):G42-51. PubMed ID: 9458772
[TBL] [Abstract][Full Text] [Related]
3. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
Campbell DJ; Kladis A; Briscoe TA; Zhuo J
Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
Griesbacher T; Rainer I; Tiran B; Fink E; Lembeck F; Peskar BA
Br J Pharmacol; 2003 May; 139(2):299-308. PubMed ID: 12770935
[TBL] [Abstract][Full Text] [Related]
5. Role of substance P and bradykinin in acute pancreatitis induced by secretory phospholipase A2.
Camargo EA; Ferreira T; Ribela MT; de Nucci G; Landucci EC; Antunes E
Pancreas; 2008 Jul; 37(1):50-5. PubMed ID: 18580444
[TBL] [Abstract][Full Text] [Related]
6. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
7. Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis.
Satake K; Ha SS; Hiura A
Pancreas; 1996 Jan; 12(1):92-7. PubMed ID: 8927625
[TBL] [Abstract][Full Text] [Related]
8. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
Turner P; Dear J; Scadding G; Foreman JC
J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
[TBL] [Abstract][Full Text] [Related]
9. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Legat FJ; Griesbacher T; Lembeck F
Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
Siragy HM; Jaffa AA; Margolius HS
Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
[TBL] [Abstract][Full Text] [Related]
11. Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats.
Griesbacher T; Kolbitsch C; Tiran B; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):557-64. PubMed ID: 8751086
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of peptide kinin B2 receptor antagonists in rats.
Carini F; Guelfi M; Lecci A; Tramontana M; Meini S; Giuliani S; Montserrat X; Pascual J; Fabbri G; Ricci R; Quartara L; Maggi CA
Can J Physiol Pharmacol; 2002 Apr; 80(4):310-22. PubMed ID: 12025966
[TBL] [Abstract][Full Text] [Related]
13. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
Cockcroft JR; Chowienczyk PJ; Brett SE; Bender N; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):317-21. PubMed ID: 7833220
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
16. Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice.
Arai Y; Takanashi H; Kitagawa H; Wirth KJ; Okayasu I
Dig Dis Sci; 1999 Apr; 44(4):845-51. PubMed ID: 10219847
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
18. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
19. Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.
Kaszala K; Végh A; Papp JG; Parratt JR
Eur J Pharmacol; 1997 Jun; 328(1):51-60. PubMed ID: 9203568
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
